コンテンツにジャンプ

トップページ > 共通部門のご案内 > 支持・緩和医療開発部門 > 提言・ポリシー・業績など > 業績 > 2016～2022年度

2016～2022年度

2022年

  1. Kurisu K, Hashimoto M, Ishizawa T, Shibayama O, Inada S, Fujisawa D, Inoguchi　H, Shimoda H, Inoue S, Ogawa A, Akechi T, Shimizu K, Uchitomi Y, Matsuyama Y,　Yoshiuchi K. Development of computer adaptive testing for measuring depression　in patients with cancer. Sci Rep. 2022 May 17;12(1):8247. [35581321](外部サイトにリンクします)
  2. Saito J, Odawara M, Takahashi H, Fujimori M, Yaguchi-Saito A, Inoue M, Uchitomi Y, Shimazu T★. Barriers and facilitative factors in the implementation of workplace health promotion activities in small and medium-sized enterprises: a qualitative study. Implement Sci Commun. 2022 Mar 2;3(1):23. [35236511](外部サイトにリンクします)
  3. Akechi T, Kubota Y, Ohtake Y, Setou N, Fujimori M, Takeuchi E, Kurata A, Okamura M, Hasuo H, Sakamoto R, Miyamoto S, Asai M, Shinozaki K, Onishi H, Shinomiya T, Okuyama T, Sakaguchi Y, Matsuoka H. Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer. Jpn J Clin Oncol. 2022 Mar 6:hyac025. [35253040](外部サイトにリンクします)
  4. Okamura M, Fujimori M★, Goto S, Obama K, Kadowaki M, Sato A, Hirayama T, Uchitomi Y. Prevalence and associated factors of psychological distress among young adult cancer patients in Japan. Palliat Support Care. 2022 Feb 28:1-7. [35225198](外部サイトにリンクします)
  5. Matsuoka A★, Fujimori M. Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer. JAMA Oncol. 2022 Apr 1;8(4):1. [35201282](外部サイトにリンクします)
  6. Sato A, Fujimori M★, Shirai Y, Umezawa S, Mori M, Jinno S, Umehashi M, Okamura M, Okusaka T, Majima Y, Miyake S, Uchitomi Y. Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study - ERRATUM. Palliat Support Care. 2022 Feb 9:1-3. [35135645](外部サイトにリンクします)
  7. Matsumoto Y, Umemura S, Okizaki A, Fujisawa D, Kobayashi N, Tanaka Y, Sasaki C, Shimizu K, Ogawa A, Kinoshita H, Uchitomi Y, Yoshiuchi K, Matsuyama Y, Morita T, Goto K, Ohe Y. Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme. Jpn J Clin Oncol. 2022 Apr 6;52(4):375-382. [35079813](外部サイトにリンクします)

 

2021年

  1. Etoh T, Fujiwara M, Yamada Y, Wada R, Higuchi Y, Inoue S, Kodama M, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Kakeda K, Shimazu T, Nakaya N, Tabata M, Uchitomi Y, Yamada N, Inagaki M. Cancer care for people with mental disorders: A qualitative survey among cancer care and psychiatric care professionals in Japan. Psychooncology. 2021 Dec;30(12):2060-2066. [34435715](外部サイトにリンクします)
  2. Inoue K, Kawashima Y, Noguchi H, Fujimori M, Akechi T, Kawanishi C, Uchitomi Y, Matsuoka YJ★. Attitude to suicide prevention and suicide intervention skills among oncology professionals: An online cross-sectional survey in Japan. Psychiatry Clin Neurosci. 2021 Dec;75(12):401-402. [34435416](外部サイトにリンクします)
  3. Fujiwara M, Yamada Y, Shimazu T, Kodama M, So R, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Takahashi H, Nakaya N, Kakeda K, Miyaji T, Hinotsu S, Harada K, Okada H, Uchitomi Y, Yamada N, Inagaki M. Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial. Acta Psychiatr Scand. 2021 Jul 9. [34242396](外部サイトにリンクします)
  4. Okamura M, Fujimori M★, Hata K, Mori M, Mack JW, Prigerson HG, Uchitomi Y. Validity and reliability of the Japanese version of the Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE) questionnaire. Palliat Support Care. 2021 Jun 30:1-7. [34190680](外部サイトにリンクします)
  5. Wada R, Fujiwara M, Yamada Y, Nakaya N, Fujimori M, So R, Kodama M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Validity and Reliability of the Japanese Version of the 12-item Self-administered World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in Patients with Schizophrenia. Acta Med Okayama. 2021 Jun;75(3):315-322 .[34176935](外部サイトにリンクします)
  6. Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, Bhandari PM, Negeri Z, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) HADS Group. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021 May 10;373:n972. [33972268](外部サイトにリンクします)
  7. Harashima S, Fujimori M★, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ. Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902). Jpn J Clin Oncol 2021 Feb 3;hyab001 [33529336](外部サイトにリンクします)
  8. Chen SH, Chen SY, Yang SC, Chien RN, Chen SH, Chu TP, Fujimori M, Tang WR. Effectiveness of communication skill training on cancer truth-telling for advanced practice nurses in Taiwan: A pilot study. Psychooncology. 2021 May;30(5):765-772. doi: 10.1002/pon.5629. Epub 2021 Jan 25. [33427382](外部サイトにリンクします)
  9. Okamura M, Fujimori M★, Sato A, Uchitomi Y. Unmet supportive care needs and associated factors among young adult cancer patients in Japan. BMC Cancer. 2021 Jan 5;21(1):17. doi: 10.1186/s12885-020-07721-4. [33402126](外部サイトにリンクします)
  10. Brehaut E, Neupane D, Levis B, Wu Y, Sun Y, Krishnan A, He C, Bhandari PM, Negeri Z, Riehm KE, Rice DB, Azar M, Yan XW, Imran M, Chiovitti MJ, Saadat N, Cuijpers P, Ioannidis JPA, Markham S, Patten SB, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Boruff JT, Kloda LA, Beraldi A, Braeken APBM, Carter G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, De Souza J, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Goebel S, Jetté N, Julião M, Keller M, Kjærgaard M, Love AW, Löwe B, Martin-Santos R, Michopoulos I, Navines R, O'Rourke SJ, Öztürk A, Pintor L, Ponsford JL, Rooney AG, Sánchez-González R, Schwarzbold ML, Sharpe M, Simard S, Singer S, Stone J, Tung KY, Turner A, Walker J, Walterfang M, White J, Benedetti A, Thombs BD. Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis. J Psychosom Res. 2020 Dec;139:110256. [33069051](外部サイトにリンクします)
  11. Fujimori M★, Sato A, Jinno S, Okusaka T, Yamaguchi T, Ikeda M, Ueno M, Ozaka M, Takayama Y, Miyaji T, Majima Y, Uchitomi Y. Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial. BMJ Open. 2020 Sep 23;10(9):e036745. [32967874](外部サイトにリンクします)
  12. Wu Y, Levis B, Ioannidis JPA, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration. Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. Psychother Psychosom. 2021;90(1):28-40. [32814337](外部サイトにリンクします)
  13. Wada S, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Sato T, Shimada K, Yoshimoto S, Daiko H, Kanemitsu Y, Kawai A, Kato T, Fujimoto H, Shimizu K★: Yokukansan for treatment of preoperative anxiety and prevention of postoperative delirium in cancer patients undergoing highly invasive surgery. J-SUPPORT 1605 (ProD Study): A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 2021 Jan;61(1):71-80. [32800969](外部サイトにリンクします)

2020年

論文

  1. Zenda S, Ryu A, Takashima A, et al. Hydrocolloid dressing as a prophylactic use for hand–foot skin reaction induced by multitargeted kinase inhibitors: protocol of a phase 3 randomised self-controlled study. BMJ Open. 2020 Oct 6;10(10):e038276. [33028559] (外部サイトにリンクします)
  2. Fujisawa D, Umemura S, Okizaki A, et al. Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020 Nov 26;10(11):e037759. [33243791] (外部サイトにリンクします)
  3. Harashima S, Fujimori M. Risk of suicide among adolescents and young adults with cancer and a need for targeted interventions. Ann Transl Med. 2020 Apr;8(7):428. [32395472] (外部サイトにリンクします)
  4. Matsuda Y, Tanimukai H, Inoue S, et al. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2020 May 5;50(5):586-593. [32215557] (外部サイトにリンクします)
  5. Chen SY, Fujimori M, Wang HM, et al. Gender Differences in Cancer Patients' Preferences for Truth-Telling in Taiwan. Cancer Nurs. 2020 Jul 8. [32649335] (外部サイトにリンクします)
  6. Higuchi Y, Fujimori M, Nakaya N, et al. Trends in smoking rates among individuals with serious psychological distress: Analysis of data from a Japanese national survey, 2007-2016. Psychiatry Res. 2020 Sep;291:113225. [32599444] (外部サイトにリンクします)
  7. Fujisawa D, Umezawa S, Fujimori M, et al. Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors. Jpn J Clin Oncol. 2020 Oct 22;50(11):1325-1329. [32776092] (外部サイトにリンクします)

その他

  1. 国立がん研究センター編. がん医療における自殺対策の手引き(2019年度版)
  2. 宮路天平. 臨床試験プロトコールに患者報告アウトカムを組み込むためのガイドライン─SPIRIT-PRO拡張版─. 薬理と治療. 48;(10): 1697-1712. 2020.

2019年

論文

  1. Wada S, Inoguchi H, Sadahiro R, et al. Preoperative Anxiety as a Predictor of Delirium in Cancer Patients: A Prospective Observational Cohort Study. World J Surg. 2019 Jan;43(1):134-142. [30128769] (外部サイトにリンクします)
  2. Hayashibara C, Inagaki M,Fujimori M, Higuchi Y, Fujiwara M, Terada S, Okamura H, Uchitomi Y, Yamada N. Confidence in communicating with patients with cancer mediates the relationship between rehabilitation therapists' autistic-like traits and perceived difficulty in communication. Palliat Support Care. 2019 Apr;17(2):186-194. [29352834](外部サイトにリンクします)
  3. Harashima S, Fujimori M, Akechi T, et al. Suicide, other externally caused injuries and cardiovascular death following a cancer diagnosis: study protocol for a nationwide population-based study in Japan (J-SUPPORT 1902). BMJ Open. 2019 Jul 4;9(7):e030681. [31278108] (外部サイトにリンクします)
  4. Mori M, Fujimori M, Ishiki H, et al. Adding a wider range and “hope for the best, and prepare for the worst” statement: Cancer patients’ preferences for prognostic communication. Oncologist. 2019;24:e943-e952. [30782978] (外部サイトにリンクします)
  5. Mori M,Fujimori M, Ishiki H, et al. The effects of adding reassurance statements: Cancer patients’ preferences for phrases in end-of-life discussions. J Pain Symptom Manage. 2019;57:1121-1129. [30818028] (外部サイトにリンクします)
  6. Mori M★, Fujimori M★ (co-primary), van Vliet L, Yamaguchi T, et al. Explicit Prognostic Disclosure to Asian Women With Breast Cancer: A Randomized Scripted Video-Vignette Study (J-SUPPORT1601). Cancer 2019;125:3320-3329. [31206639] (外部サイトにリンクします)
  7. Wada S, Sadahiro R, Matsuoka YJ, et al. Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial. Trials. 2019 Feb 8;20(1):110. [30736826]  (外部サイトにリンクします)
  8. Fujiwara M, Inagaki M, Shimazu T, et al. A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study. BMJ Open. Nov 2;9(11):e032955. 2019. [31678957]  (外部サイトにリンクします)
  9. Imai F, Momino K, Katsuki F, et al. Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study Jpn J Clin Oncol 49: 537-544, 2019. [30793156]  (外部サイトにリンクします)
  10. Hashimoto H, Abe M, Tokuyama O, et al. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. THE LANCET ONCOLOGY Published online December 11, 2019 [31838011]  (外部サイトにリンクします)

その他

2年次知的財産権
特願　2019-017498　
出願日　2019年2月1日　
発明者　明智龍男、山口拓洋
出願人　名古屋市立大学、東北大学
名称　サービス提供支援装置及びプログラム

2018年

論文

  1. Zenda S, Yamaguchi T, Yokota T, et al. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.  BMC cancer. 2018 Sep 6;18(1)873 doi: 10.1186/s12885-018-4763-1.[30189840]  (外部サイトにリンクします)
  2. Akechi T, Yamaguchi T, Uchida M, et al.  Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention  to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial. BMJ Open. 2018 Nov 8;8(11):e024794.[30413519]  (外部サイトにリンクします)
  3. Hashimoto H, Abe M, Yanai T, et al. Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy. Jpn J Clin Oncol. 2018 Oct 1;48(10):950-952.doi: 10.1093/jjco/hyy114 [30124989]  (外部サイトにリンクします)
  4. Shibayama O, Yoshiuchi K, Inagaki M, et al. Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy. Int J Clin Oncol. 2018.[30168090]  (外部サイトにリンクします)
  5. Yamada Y, Fujimori M, Shirai Y, et al. Changes in Physicians' Intrapersonal Empathy After a Communication Skills Training in Japan. Acad Med. 2018 Dec;93(12):1821-1826. [30134272]  (外部サイトにリンクします)
  6. Kako J, Morita T, Yamaguchi T, et al. Fan Therapy Is Effective in Relieving Dyspnea in Patients With Terminally Ill Cancer: A Parallel-Arm, Randomized Controlled Trial. J Pain Symptom Manage. 2018 Oct;56(4):493-500. [30009968]  (外部サイトにリンクします)
  7. Fujiwara M, Inagaki M, Nakaya N, et al. Smoking among adults with serious psychological distress: Analysis of anonymized data from a national cross-sectional survey in Japan. J Affect Disord. 2018 Oct 15;239:131-137. [30005326]  (外部サイトにリンクします)
  8. Hamano J, Morita T, Mori M, et al. Talking About Palliative Sedation With the Family: Informed Consent vs. Assent and a Better Framework for Explaining Potential Risks. J Pain Symptom Manage. 2018 Sep;56(3):e5-e8. [29772282]  (外部サイトにリンクします)
  9. Fujiwara M, Inagaki M, Nakaya N, et al. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan. Cancer. 2018 Feb 1;124(3):555-562. [29076156]  (外部サイトにリンクします)
  10. Kokubun H, Takigawa C, Miyano K, et al. A novel method for determination of methadone in the serum by high-performance liquid chromatography with electrochemical detection. Biol Pharm Bull, 41 (4): 649-651, 2018. [29607939]  (外部サイトにリンクします)
  11. Meguro Y, Miyano K, Hirayama S, et al. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. J Pharmacol Sci, 137 (1): 67-75, 2018. [29716811]  (外部サイトにリンクします)
  12. Miyano K, Nonaka M, Uzu M, et al. Multifunctional actions of Ninjinyoeito, a Japanese kampo medicine: Accumulated scientific evidence based on experiments with cells and animal models, and clinical studies. Front Nutr, 5: 93, 2018. [30349821]  (外部サイトにリンクします)
  13. Terawaki K, Kashiwase Y, Uzu M, et al. Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85AsZ2 cells in rats. Oncotarget, 9 (78): 34748-34764, 2018. [30410674]  (外部サイトにリンクします)
  14. Ishiki H, Yamaguchi T, Matsumoto Y, et al. Effect of early palliative care: complex intervention and complex results. Lancet Oncol. 2018; 19(5): e221. [29726380]  (外部サイトにリンクします)
  15. 全田貞幹. 支持療法に関する臨床研究グループ（J-SUPPORT）頭頸部癌　44(3):276-279. 2018年10月.

その他

1. 「支持療法・緩和治療領域研究ポリシー（総論）」公開について,　国立がん研究センター・日本医療研究開発機構[AMED]との連名でプレスリリース,　2018年12月
2. 「支持療法・緩和治療領域研究ポリシー（総論）Ver.1.0」　国立がん研究センター中央病院支持療法開発部門ホームページ上で公開　2018年12月

2017年

論文

  1. Fujimori M, Akechi T, Uchitomi Y. Factors associated with patient preferences for communication of bad news. Palliat Support Care. 2017 Jun;15(3):328-335. [27804909]  (外部サイトにリンクします)
  2. Fujiwara M, Inagaki M, Nakaya N, et al. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan. Cancer. 2017. [29076156]  (外部サイトにリンクします)
  3. Fujiwara M, Inagaki M, Nakaya N, et al. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017. [28875514]  (外部サイトにリンクします)
  4. Higuchi Y, Inagaki M, Koyama T, et al. Emotional Intelligence and its Effect on Pharmacists and Pharmacy Students with Autistic-like Traits. Am J Pharm Educ. 2017; 81(4): 74. [28630515]  (外部サイトにリンクします)
  5. Kako J, Morita T, Yamaguchi T, et al. Evaluation of the Appropriate Washout Period Following Fan Therapy for Dyspnea in Patients With Advanced Cancer: A Pilot Study. Am J Hosp Palliat Care. 2017. [28468508]  (外部サイトにリンクします)

2016年

論文

  1. Zenda S, Ota Y, Tachibana H, et al. A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients. J Radiat Res. 2016 ; 57(3): 301-6. [26850926]  (外部サイトにリンクします)
  2. Inoguchi H, Shimizu K, Shimoda H, et al. Screening for untreated depression in cancer patients: a Japanese experience. Jpn J Clin Oncol. 2016 Nov 1;46(11):993-999. [27566975]  (外部サイトにリンクします)
  3. Fujiwara M, Inagaki M, Higuchi Y, et al. An Open-Label Feasibility Trial of Repetitive ranscranial Magnetic Stimulation for Treatment-Resistant Major Depressive Episodes. Acta Med Okayama. 2016; 70(4): 307-11. [27549679]  (外部サイトにリンクします) 
  4. Higuchi Y, Inagaki M, Koyama T, et al. A cross-sectional study of psychological distress, burnout, and the associated risk factors in hospital pharmacists in Japan. BMC Public Health. 2016; 16: 534. [27392676]  (外部サイトにリンクします)
提言・ポリシー・業績など